2025 CPT code 96402
Effective Date: N/A Medicine - Chemotherapy Administration Feed
Chemotherapy administration, subcutaneous or intramuscular; hormonal anti-neoplastic
Modifiers may be applicable in certain scenarios, such as reduced services (modifier 52), discontinued procedure (modifier 53), or distinct procedural service (modifier 59), amongst others.
In simple words: This procedure involves administering anti-cancer hormonal medication through an injection under the skin (subcutaneous) or into a muscle (intramuscular).
This code describes the administration of hormonal anti-neoplastic chemotherapy drugs via subcutaneous or intramuscular injection.
Example 1: A patient with breast cancer receives a subcutaneous injection of fulvestrant, a hormonal anti-neoplastic agent., A patient with prostate cancer receives an intramuscular injection of leuprolide, a hormonal anti-neoplastic agent., A patient receives an injection of degarelix, which is administered subcutaneously.
Documentation should include the type of hormonal anti-neoplastic drug administered, the dosage, the route of administration (subcutaneous or intramuscular), the date and time of administration, and the patient's tolerance of the procedure.
- Place of Service:Office"Outpatient Hospital""Inpatient Hospital""Home"